Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia

Details for Australian Patent Application No. 2006299078 (hide)

Owner INSERM (Institut National de la Sante et de la Recherche Medicale)

Inventors Guegan, Christelle; Onteniente, Brigitte; Couriaud, Cecile; Braudeau, Jerome

Agent Shelston IP

Pub. Number AU-A-2006299078

PCT Pub. Number WO2007/039254

Priority 05292028.7 29.09.05 EP

Filing date 29 September 2006

Wipo publication date 12 April 2007

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039254 Priority application(s): WO2007/039254

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299079-Tumor angiogenesis associated genes and a method for their identification

2006299061